BIO-Key International

Quarterly Financials

Values in thousands 2024-09-30 2024-06-30 2024-03-31 2023-12-31
Revenue
$2,144
$1,141
$2,181
$2,270
Gross Profit
1,679
879
1,881
2,270
EBITDA
-580
-1,553
-407
-4,300
EBIT
-1,654
-522
-200
Net Income
-738
-1,666
-510
-4,099
Net Change In Cash
2,144
1,141
2,181
2,270
Free Cash Flow
-1,297
-1,420
295
-1,532
Cash
1,801
1,260
690
511
Basic Shares
1,889
1,663
1,615
504

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$7,754
$7,020
$5,114
$2,836
Gross Profit
1,431
4,980
3,441
2,041
EBITDA
-7,847
-11,373
-4,533
-4,903
EBIT
-8,437
-11,919
-5,047
-5,330
Net Income
-8,521
-10,742
-4,569
-13,590
Net Change In Cash
7,754
7,020
5,114
2,836
Cost of Revenue
16,914
Free Cash Flow
-3,794
-6,311
-9,020
-4,985
Cash
511
2,635
7,754
16,993
Basic Shares
560
450
432
261

Earnings Calls

Quarter EPS
2024-09-30
-$0.39
2024-06-30
-$1
2024-03-31
-$2.88
2023-09-30
-$0.08